Compare RAY & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAY | MBAI |
|---|---|---|
| Founded | 1993 | 2004 |
| Country | Hong Kong | Israel |
| Employees | N/A | 85 |
| Industry | Consumer Electronics/Appliances | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 10.3M |
| IPO Year | 2022 | N/A |
| Metric | RAY | MBAI |
|---|---|---|
| Price | $2.90 | $1.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.6K | ★ 64.2K |
| Earning Date | 07-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.15 | $1.29 |
| 52 Week High | $5.99 | $3.92 |
| Indicator | RAY | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 30.52 | 42.95 |
| Support Level | $2.31 | $1.30 |
| Resistance Level | $4.16 | $1.83 |
| Average True Range (ATR) | 0.55 | 0.10 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 3.90 | 27.45 |
Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.